21st September 2026, Monday

TechPharus

Latest Posts

HealthTech News

  • U.S. alcohol use falls for first time since the COVID-19 pandemic but remains above pre-pandemic levels
    on September 21, 2026 at 9:00 pm

    Alcohol use among U.S. adults has fallen for the first time since the COVID-19 pandemic began, though rates remain higher than pre-pandemic levels, according to a new Keck Medicine of USC study published in Annals of Internal Medicine.

  • A stubborn medical mystery: Insights into signs and origins of a disorder that causes overly flexible joints
    on September 21, 2026 at 9:00 pm

    Some genetic disorders have a clear connection between the affected gene product and the suite of symptoms produced. But genes do not work in isolation, and many other conditions can be bafflingly complex, as when an affected gene product affects the function of many tissues throughout the body. Ehlers-Danlos syndrome, a collection of genetic disorders of connective tissue, is particularly challenging for those who live with it because of its varied and poorly understood effects.

  • Experimental drug raises energy expenditure but fails to activate brown fat in human study
    on September 21, 2026 at 8:40 pm

    Brown fat burns energy to generate heat and is therefore considered a promising target for new obesity treatments. Researchers at the University of Basel and University Hospital Basel have tested whether a drug can activate brown fat in humans. Their results show that a pharmaceutical approach may be more difficult than expected.

  • Expanded newborn screening identifies virus that can lead to hearing loss and developmental delays
    on September 21, 2026 at 8:20 pm

    Researchers at Cleveland Clinic Children’s have developed a new screening program for congenital cytomegalovirus, the most common infection passed from mothers to babies during pregnancy. While many babies with congenital cytomegalovirus have no obvious symptoms, some can develop hearing loss, developmental delays or other medical complications as they grow.

  • GLP-1s linked to nutritional deficiencies in children
    on September 21, 2026 at 8:20 pm

    Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) within the first year—according to a new study published in the journal Childhood Obesity. Vitamin D deficiency was the most common, identified in 12.4% of children within one year of GLP-1 treatment.